Weight loss and malnutrition in patients with chronic graft-versus-host disease

被引:49
作者
Jacobsohn, DA [1 ]
Margolis, J [1 ]
Doherty, J [1 ]
Anders, V [1 ]
Vogelsang, GB [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
关键词
chronic graft-versus-host disease; weight loss; malnutrition; hematopoietic stem cell transplantation;
D O I
10.1038/sj.bmt.1703352
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
It is well known that weight loss occurs in patients with chronic graft-versus-host disease. However, the severity and frequency of weight loss in this population have not been adequately described. Recent data suggest that a body-mass index (BMI) below 21.9 is an independent risk factor for mortality. In our analysis we have shown that out of 93 patients with cGVHD, 43% are malnourished as evidenced by a BMI less than 21.9 and 14% are severely malnourished (BMI less than 18.5). In addition, there is a clear trend showing that patients with active, ongoing cGVHD have lower BMIs (P = 0.02). Furthermore, we show that many symptoms thought to contribute to weight loss in patients with cGVHD, such as odynophagia and oral sensitivity, are not related to weight loss in our population. We conclude that, in all likelihood, unknown causes still exist that are responsible for weight loss in this group of patients. Elevated resting energy expenditure and elevated serum tumor necrosis factor-a are potential contributors to weight loss that will be tested in future studies. We also conclude that treating cGVHD aggressively may help reverse weight loss and malnutrition, which may be independent risk factors for mortality in this population.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 33 条
  • [1] ATKINSON K, 1982, BLOOD, V60, P714
  • [2] ATKINSON K, 1990, BONE MARROW TRANSPL, V5, P69
  • [3] MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES
    BEATTY, PG
    HANSEN, JA
    LONGTON, GM
    THOMAS, ED
    SANDERS, JE
    MARTIN, PJ
    BEARMAN, SI
    ANASETTI, C
    PETERSDORF, EW
    MICKELSON, EM
    PEPE, MS
    APPELBAUM, FR
    BUCKNER, CD
    CLIFT, RA
    PETERSEN, FB
    STEWART, PS
    STORB, RF
    SULLIVAN, KM
    TESLER, MC
    WITHERSPOON, RP
    [J]. TRANSPLANTATION, 1991, 51 (02) : 443 - 447
  • [4] Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
    Bensinger, WI
    Martin, PJ
    Storer, B
    Clift, R
    Forman, SJ
    Negrin, R
    Kashyap, A
    Flowers, MED
    Lilleby, K
    Chauncey, TR
    Storb, R
    Appelbaum, FR
    Rowley, S
    Heimfeld, S
    Blume, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) : 175 - 181
  • [5] Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle
    Blaise, D
    Kuentz, M
    Fortanier, C
    Bourhis, JH
    Milpied, N
    Sutton, L
    Jouet, JP
    Attal, M
    Bordigoni, P
    Cahn, JY
    Boiron, JM
    Schuller, MP
    Moatti, JP
    Michalle, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 537 - 546
  • [6] Body-mass index and mortality in a prospective cohort of US adults
    Calle, EE
    Thun, MJ
    Petrelli, JM
    Rodriguez, C
    Heath, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) : 1097 - 1105
  • [7] CHANDRA RK, 1983, LANCET, V1, P688
  • [8] Farmer E R, 1986, Adv Dermatol, V1, P173
  • [9] Pathophysiology and treatment of graft-versus-host disease
    Flowers, MED
    Kansu, E
    Sullivan, KM
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (05) : 1091 - +
  • [10] FREDRIX EWHM, 1991, CANCER, V68, P1616, DOI 10.1002/1097-0142(19911001)68:7<1616::AID-CNCR2820680725>3.0.CO